Search results for "slas europe 2018"
Selected Filters:
Beckman Coulter acquires artificial intelligence company providing evidence-based clinical decision support for emergency departments
StoCastic’s TriageGo, a triage decision support tool that integrates electronic health records and emergency department workflows, will be a cornerstone of Beckman Coulter’s Clinical Decision Support portfolio
Thermo Fisher, Daiichi Sankyo partner on global companion diagnostic device
The Oncomine Dx target test aims to identify HER2 gene mutations in non-small lung cancer patients
Standardization Capability on Spectral Flow Cytometers
FTIR Analysis of Legal Cannabis Derived Products
Biden–Harris Administration finalizes first national drinking water standard
EPA announces $1B investment through president Biden’s investing in America agenda to address PFAS in drinking water
ECLIPSE study demonstrates efficacy of Shield blood-based test for colorectal cancer screening
Study shows blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90%
Horizon Discovery Takes Exclusive License for Novel Transposon-Based Gene Editing Technology Platform
New technology has immediate applications in biomanufacturing, diagnostics, cell and gene therapy
Peer Review Research Demonstrates Benefits of Chromatrap Solid State ChIP Technology
Studies demonstrate pioneering research possible using ChIP technology
Beckman Coulter Diagnostics Showcases the New DxN VERIS Molecular Diagnostics System at ESCV Edinburgh
Unique System Proven to Improve Laboratory Workflow and Productivity for Infectious Disease
Nitrosamine impurities: How LGC experts are protecting public health against carcinogens
Mike Ludlow explains the dangers associated with nitrosamines and how his team protects people from overexposure to possible carcinogens found in medications
Detecting Pathogens in Infant Formula Using Next-Generation Sequencing
Hemlibra Provides Control of Bleeding in People with or without Factor VIII Inhibitors
Roche’s Hemlibra reduced treated bleeds by 96 percent compared to no prophylaxis in phase III HAVEN 3 study in haemophilia A without factor VIII inhibitors
How to Achieve Quality Control of Your Samples in Biorepositories
Achieving Sample Quality Control in Biorepositories: Presentation Highlights
Biosimilar development: Experts discuss analytical characterization toolkits for antibody therapeutics
Experts from Xbrane Biopharma discuss the biosimilar development process and how bioassays are the driving force behind reduced cost and accelerated timelines





















